Literature DB >> 16966742

An evaluation of Oregon's evidence-based Practitioner-Managed Prescription Drug Plan.

Daniel M Hartung1, Kathy L Ketchum, Dean G Haxby.   

Abstract

This paper describes Oregon's implementation of its publicly developed, evidence-based, Practitioner-Managed Prescription Drug Plan (PMPDP). Oregon's PMPDP was initially self-enforced with a dispense as written (DAW) exception process, followed by an educational prior authorization (soft PA) method, and finally no active enforcement. Market-share trends indicate that the educational prior authorization process was most effective at increasing the use of preferred agents. Pharmacy costs decreased 9.1 percent and 17.7 percent after implementation of the DAW and soft PA policies, respectively. Data from nonenforced PMPDP classes showed no change; this suggests the need for effective methods to encourage PMPDP compliance.

Mesh:

Year:  2006        PMID: 16966742     DOI: 10.1377/hlthaff.25.5.1423

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  5 in total

1.  Potential savings from an evidence-based consumer-oriented public education campaign on prescription drugs.

Authors:  Julie M Donohue; Michael A Fischer; Haiden A Huskamp; Joel S Weissman
Journal:  Health Serv Res       Date:  2008-05-13       Impact factor: 3.402

Review 2.  Pharmaceutical policies: effects of restrictions on reimbursement.

Authors:  Carolyn J Green; Malcolm Maclure; Patricia M Fortin; Craig R Ramsay; Morten Aaserud; Stan Bardal
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

3.  Translating medical effectiveness research into policy: lessons from the California Health Benefits Review Program.

Authors:  Janet M Coffman; Mi-Kyung Hong; Wade M Aubry; Harold S Luft; Edward Yelin
Journal:  Milbank Q       Date:  2009-12       Impact factor: 4.911

Review 4.  Confusing inequitable medicare prescription drug benefit.

Authors:  Gail E Shearer
Journal:  J Gen Intern Med       Date:  2007-02       Impact factor: 5.128

Review 5.  Systematic review on quality control for drug management programs: is quality reported in the literature?

Authors:  Anke-Peggy Holtorf; Carrie McAdam-Marx; David Schaaf; Benjamin Eng; Gary Oderda
Journal:  BMC Health Serv Res       Date:  2009-02-25       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.